University of Miami Health System

Division Director Associate and/or Professor Level– Diagnostic Radiology, Nuclear Medicine - Dual Boarded

Miami, FL

full-time
Inpatient and outpatient

Job Functions

  • Provide clinical oversight and leadership to the nuclear medicine division, including study interpretation.

  • Lead the growth and expansion of the nuclear medicine clinical operation and services across UHealth.

  • Manage/develop a team of physicians, residents/fellows, technologists, and support staff (e.g. hiring, training, evaluating performance). This includes proposing mentorship and research initiatives.

  • Ensure regulatory and accreditation compliance, including maintaining appropriate licensure and certification.

  • Coordinate with faculty/staff and departmental leadership to streamline patient care and operational efficiency.

  • Develop and implement clinical programs to ensure the highest level of patient care and safety.

  • Foster a culture of excellence by promoting professional development, research, and superior education.

  • Participate in quality improvement initiatives to improve patient outcomes and operational efficiency.

  • Collaborate with other healthcare providers and stakeholders to ensure effective coordination of care.

  • Manage and coordinate Nuclear Medicine therapies across UHealth’s system, such as multidisciplinary workups and therapies in the realm of Theranostics, including experimental treatments.

  • Multidisciplinary collaboration for clinical and innovation initiatives with other departments, such as: Medical Oncology, Cardiology, Radiation Oncology, Endocrinology, and others to foster common approaches.

This list of duties and responsibilities is not intended to be all-inclusive and may be expanded to include other duties or responsibilities as necessary.

Qualifications

  • Medical Doctor degree and board certification in both Diagnostic Radiology (ABR) and Nuclear Medicine (ABNM). Dual Boarded.

  • Academic rank of Associate or Full Professor.

  • Minimum of 7 years of experience in nuclear medicine interpretation and reporting.

  • Experience in managing a team of physicians, scientists, residents/fellows, technologists, and support staff.

  • Knowledge of regulatory requirements and accreditation standards related to nuclear medicine.

  • Strong communication and collaboration skills. Track record of multidisciplinary research.

  • Demonstrated commitment to high quality patient care and safety. A track record of developing tailored diagnostic and therapeutic nuclear medicine regimens in complex clinical scenarios will be noted.

  • Ability to think critically, solve complex problems, and to interact and communicate effectively.

  • Experience with clinical program development and implementation.

  • Expertise in the interpretation and reporting of nuclear medicine studies, as well as experience in managing a team of physicians, scientists, residents/fellows, technologists, and support staff.

  • Excellent nuclear medicine background with working experience in all facets of nuclear medicine, molecular imaging and radiopharmaceutical therapies.

  • A vision in the burgeoning realm of Theranostics is highly desired, which the candidate should be prepared to articulate.

  • Resident/Fellow education and training in nuclear medicine is another critical aspect. .

  • Experience in Radiopharmaceutical Therapy and Theranostics is highly desired as the Division is quite active in conventional and new therapies for thyroid cancer, lymphoma, neuroendocrine tumors, and prostate cancer, to name a few.

  • Excellence in academic achievement as demonstrated by a record of scientific presentation and/or publications.

Location Insights

  • A+

    Access to Restaurants

  • A

    Access to Outdoor Activities

  • A

    Access to Parks

  • B+

    Commute

  • B+

    Public Schools

  • B+

    Overall

  • Total Population

    454,279

  • Median Rent

    $1,183

  • Median Home Value

    $317,700

  • Median Income

    $39,049

Posted April 28, 2024